Showing results (441-450 of 1,372) with videos related to

Sort By:
Pageof 138
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 31, 2022
Blood-brain barrier dysfunction and reduced cerebrospinal fluid levels of soluble amyloid precursor protein-β in patients with subcortical small-vessel diseasePetronella Kettunen, Maria Bjerke, Carl Eckerström, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 7, 2022
Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal studyConcepcion Padilla, Victor Montal, Madeleine J Walpert, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 7, 2022
Role of tau deposition in early cognitive decline in Down syndromeSigan L Hartley, Benjamin L Handen, Dana Tudorascu, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 16, 2018
The conceptual relevance of assessment measures in patients with mild/mild-moderate Alzheimer's diseaseAnn Hartry, Natalie V J Aldhouse, Tamara Al-Zubeidi, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 18, 2019
Perifovea retinal thickness as an ophthalmic biomarker for mild cognitive impairment and early Alzheimer's diseaseRui Tao, Zhaozeng Lu, Ding Ding, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 28, 2019
Progress update from the hippocampal subfields groupRosanna K Olsen, Valerie A Carr, Ana M Daugherty, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 12, 2019
Factors affecting the harmonization of disease-related metabolic brain pattern expression quantification in [18F]FDG-PET (PETMETPAT)Rosalie V Kogan, Bas A de Jong, Remco J Renken, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 28, 2017
Neuroticism, depression, and anxiety traits exacerbate the state of cognitive impairment and hippocampal vulnerability to Alzheimer's diseaseValérie Zufferey, Alessia Donati, Julius Popp, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 28, 2017
A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortiumAlden L Gross, Jason J Hassenstab, Sterling C Johnson, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 28, 2017
Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromesRachel H Tan, Jillian J Kril, Yue Yang, et al.
Pageof 138